Profile data is unavailable for this security.
About the company
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
- Revenue in USD (TTM)402.19m
- Net income in USD2.08m
- Incorporated2020
- Employees1.00k
- LocationGeneDx Holdings Corp333 Ludlow StreetNorth Tower, 6Th FloorSTAMFORD 06902United StatesUSA
- Phone+1 (617) 780-8742
- Fax+1 (302) 636-5454
- Websitehttps://sema4.com/
More ▼
Mergers & acquisitions
| Acquired company | WGS:NSQ since announced | Transaction value |
|---|---|---|
| Fabric Genomics Inc | -11.81% | 51.00m |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NeoGenomics, Inc. | 709.16m | -113.47m | 1.47bn | 2.20k | -- | 1.75 | -- | 2.08 | -0.8877 | -0.8877 | 5.55 | 6.50 | 0.4703 | 15.15 | 4.62 | 322,346.40 | -7.52 | -4.23 | -8.66 | -4.55 | 43.46 | 40.72 | -16.00 | -11.71 | 3.62 | -- | 0.2894 | -- | 11.65 | 10.07 | 10.51 | -- | 15.44 | -- |
| Acadia Healthcare Company Inc | 3.27bn | 107.36m | 1.55bn | 19.19k | 14.22 | 0.486 | 5.13 | 0.4738 | 1.18 | 1.18 | 35.79 | 34.50 | 0.5317 | -- | 8.02 | 170,151.50 | 1.94 | 3.14 | 2.19 | 3.65 | -- | -- | 3.64 | 6.72 | 1.43 | 3.39 | 0.4125 | -- | 7.69 | 9.45 | 1,279.73 | 37.45 | 24.30 | -- |
| Aveanna Healthcare Holdings Inc | 2.29bn | 75.46m | 1.66bn | 3.50k | 21.56 | 167.10 | 19.33 | 0.7233 | 0.3678 | 0.3678 | 11.01 | 0.0475 | 1.33 | -- | 7.69 | 654,454.60 | 4.37 | -10.76 | 5.72 | -13.00 | 33.57 | 31.32 | 3.29 | -11.05 | -- | 1.83 | 0.9933 | -- | 6.82 | 7.90 | 91.88 | -- | -17.60 | -- |
| Progyny Inc | 1.27bn | 56.57m | 1.78bn | 675.00 | 33.12 | 3.18 | 29.23 | 1.41 | 0.6246 | 0.6246 | 13.95 | 6.50 | 1.74 | -- | 4.76 | 1,879,539.00 | 7.77 | 11.31 | 10.92 | 15.54 | 22.94 | 21.65 | 4.46 | 6.66 | -- | -- | 0.00 | 0.00 | 7.22 | 38.42 | -12.41 | -- | 12.83 | -- |
| Pediatrix Medical Group Inc | 1.92bn | 162.19m | 1.85bn | 2.15k | 11.30 | 2.07 | 9.98 | 0.9613 | 1.90 | 1.90 | 22.60 | 10.38 | 0.8991 | -- | 7.42 | 894,159.10 | 7.59 | 0.0108 | 9.24 | 0.0129 | -- | -- | 8.44 | 0.0155 | -- | 14.61 | 0.4035 | 0.00 | 0.9164 | 2.49 | -64.00 | -- | 2.71 | -- |
| Surgery Partners Inc | 3.29bn | -171.40m | 2.00bn | 15.00k | -- | 1.15 | 11.54 | 0.6081 | -1.36 | -1.36 | 25.94 | 13.41 | 0.4248 | 27.71 | 5.86 | 219,206.70 | 0.301 | 0.9726 | 0.4297 | 1.36 | 26.57 | 26.23 | 0.7086 | 2.46 | 1.72 | 2.29 | 0.5007 | -- | 13.52 | 11.20 | -1,312.61 | -- | 4.20 | -- |
| Select Medical Holdings Corp | 4.06bn | -34.63m | 2.03bn | 30.00k | -- | 1.20 | 12.39 | 0.50 | -0.2592 | 0.9205 | 32.71 | 13.64 | 0.5927 | -- | 4.30 | 135,206.50 | 0.2021 | 3.00 | 0.2564 | 3.85 | 11.92 | 12.70 | 0.341 | 4.19 | -- | 2.25 | 0.4673 | 32.73 | 7.48 | -0.9982 | 10.99 | -15.13 | 7.17 | -- |
| Addus Homecare Corporation | 1.35bn | 85.65m | 2.10bn | 6.17k | 24.37 | 2.00 | 20.80 | 1.56 | 4.67 | 4.67 | 73.43 | 56.81 | 1.05 | -- | 11.68 | 218,426.00 | 6.65 | 5.39 | 7.58 | 6.25 | 32.66 | 31.71 | 6.36 | 5.43 | -- | 12.66 | 0.1255 | 0.00 | 9.06 | 12.22 | 17.73 | 23.31 | 5.54 | -- |
| CorVel Corp | 941.49m | 105.73m | 2.52bn | 5.08k | 24.10 | 6.70 | 18.39 | 2.67 | 2.04 | 2.04 | 18.18 | 7.35 | 1.59 | -- | 9.04 | 185,515.90 | 17.87 | 16.16 | 29.52 | 26.66 | 24.22 | 22.60 | 11.23 | 9.71 | -- | -- | 0.00 | 0.00 | 12.61 | 8.62 | 24.80 | 14.97 | 2.02 | -- |
| GeneDx Holdings Corp | 402.19m | 2.08m | 2.61bn | 1.00k | 1,455.68 | 8.91 | 79.50 | 6.48 | 0.0619 | 0.0619 | 14.05 | 10.12 | 0.891 | 11.44 | 8.11 | 402,190.00 | 0.4615 | -62.35 | 0.5647 | -78.90 | 69.65 | 20.78 | 0.5179 | -111.42 | 2.59 | 4.05 | 0.153 | -- | 50.79 | 9.26 | 70.25 | -- | -18.70 | -- |
| National Healthcare Corp | 1.50bn | 101.25m | 2.63bn | 14.96k | 26.18 | 2.50 | 17.78 | 1.75 | 6.48 | 6.48 | 96.03 | 67.87 | 0.9574 | 117.59 | 11.49 | 100,295.30 | 6.60 | 5.45 | 7.97 | 6.61 | 38.55 | 39.29 | 6.89 | 6.54 | 1.72 | -- | 0.0646 | 46.43 | 14.53 | 5.58 | 52.59 | 8.36 | 0.893 | 3.30 |
| Lifestance Health Group Inc | 1.37bn | -9.12m | 2.73bn | 8.00k | -- | 1.83 | 58.34 | 2.00 | -0.0239 | -0.0239 | 3.54 | 3.84 | 0.6425 | -- | 9.80 | 133,839.30 | -0.4283 | -8.96 | -0.4785 | -9.73 | -- | -- | -0.6667 | -19.11 | -- | 0.5684 | 0.1589 | -- | 18.50 | 42.55 | 69.16 | -- | 8.54 | -- |
| Privia Health Group Inc | 2.04bn | 18.17m | 2.75bn | 1.14k | 157.54 | 3.88 | 81.91 | 1.35 | 0.1421 | 0.1421 | 15.99 | 5.77 | 1.64 | -- | 4.50 | 1,791,727.00 | 1.96 | -3.81 | 3.68 | -6.27 | 10.17 | 9.48 | 1.20 | -2.05 | -- | -- | 0.00 | -- | 4.74 | 17.17 | -37.67 | 11.78 | -- | -- |
| Concentra Group Holdings Parent Inc | 2.09bn | 151.68m | 3.02bn | 8.76k | 11.56 | 7.83 | 13.08 | 1.44 | 2.04 | 2.04 | 20.68 | 3.01 | 0.7848 | -- | 8.17 | 238,567.90 | 5.99 | -- | 6.79 | -- | 28.36 | -- | 7.63 | -- | -- | 3.07 | 0.7972 | -- | 3.38 | -- | -7.45 | -- | -- | -- |
| Hims & Hers Health Inc | 2.21bn | 133.79m | 3.71bn | 1.64k | 30.31 | 6.38 | 21.04 | 1.68 | 0.5378 | 0.5378 | 8.85 | 2.55 | 1.56 | 7.12 | 96.33 | 1,350,616.00 | 9.44 | -3.91 | 11.99 | -4.74 | 75.01 | -- | 6.05 | -2.35 | 1.64 | -- | 0.6257 | -- | 69.33 | -- | 635.28 | 155.96 | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to GeneDx Holdings Corp's reporting currency: US Dollar USD
47.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Corvex Management LPas of 30 Sep 2025 | 3.06m | 10.65% |
| Casdin Capital LLCas of 30 Sep 2025 | 3.01m | 10.47% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 1.34m | 4.67% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 2025 | 1.02m | 3.55% |
| Westfield Capital Management Co. LPas of 31 Dec 2025 | 1.02m | 3.55% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.02m | 3.54% |
| Oracle Investment Management, Inc.as of 30 Sep 2025 | 889.95k | 3.10% |
| Summit Partners Public Asset Management LLCas of 30 Sep 2025 | 823.57k | 2.87% |
| William Blair Investment Management LLCas of 31 Dec 2025 | 809.21k | 2.82% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2025 | 718.00k | 2.50% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
